Role of β-endorphin on phospholipase production in Malassezia pachydermatis in dogs: New insights into the pathogenesis of this yeast

Medical Mycology

Volumn 45, Issue 1, 2007, Pages 11-15

  Cafarchia, C ^a   Dell'Aquila, M E ^a   Capelli, G ^b   Minoia, P ^a   Otranto, D ^a  

^a UNIVERSITY OF BARI   (Italy)

^b ISTITUTO ZOOPROFILATTICO SPERIMENTALE DELLE VENEZIE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ENDORPHIN; PHOSPHOLIPASE;

ARTICLE; CELL DIFFERENTIATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DERMATITIS; DOG DISEASE; ENZYME ACTIVITY; ENZYME SYNTHESIS; FUNGAL CELL; FUNGUS ISOLATION; MALASSEZIA PACHYDERMATIS; NONHUMAN; PATHOGENESIS; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; QUANTITATIVE ANALYSIS; SKIN DEFECT; STATISTICAL ANALYSIS; SUSPENSION; ANIMAL; ANIMAL DISEASE; BIOSYNTHESIS; DERMATOMYCOSIS; DOG; DOSE RESPONSE; DRUG EFFECT; ENZYMOLOGY; ISOLATION AND PURIFICATION; MALASSEZIA; METABOLISM; MICROBIOLOGY;

CANIS FAMILIARIS; MALASSEZIA; MALASSEZIA PACHYDERMATIS;

ANIMALS; BETA-ENDORPHIN; DERMATOMYCOSES; DOG DISEASES; DOGS; DOSE-RESPONSE RELATIONSHIP, DRUG; MALASSEZIA; PHOSPHOLIPASES;

EID: 34249723313     PISSN: 13693786     EISSN: 14602709     Source Type: Journal    
DOI: 10.1080/13693780600962718     Document Type: Article

References (34)

1. Guillot, J. and Bond, R. (1999) Malassezia pachydermatis: A review. Med Mycol, 4, pp. 72-73.
2. Gúho, E., Midgley, G. and Guillot, J. (1996) The genus Malassezia with description of four new species. Antonie van Leeuwenhoek, 69, pp. 335-337.
3. Guillot, J., Chermette, R. and Guého, E. (1994) Prevalénce du genre Malassezia chez les Mammiféres. J Mycol Med, 4, pp. 72-79.
4. Simmons, RB and Guého, E. (1990) A new species of Malassezia. Mycol, 94, pp. 1146-1149.
5. Sugita, T., Takashima, M., Kodama, M., Tsuboi, R. and Nishikawa, A. (2003) Description of a new yeast species, Malassezia japonica and its detection in patients with atopic dermatitis and healthy subjects. J Clin Microbiol, 41, pp. 4695-4699.
6. Sugita, T., Takashima, M. and Shinoda, T. (2002) New yeast species, Malassezia dermatis, isolated from patients with atopic dermatitis. J Clin Microbiol, 40, pp. 1363-1367.
7. Chen, TA and Hill, PB. (2005) The biology of Malassezia organisms and their ability to induce immune responses and skin disease. Vet Dermatol, 16, pp. 4-26.
8. Bond, R. and Lloyd, D. H. (1997) Skin and mucosal populations of Malassezia pachydermatis in healthy and seborrhoeic Basset hound. Vet Dermatol, 8, pp. 101-106.
9. Cafarchia, C., Gallo, S. and Romito, D. (2005) Frequency, body distribution and population size of Malassezia yeasts in healthy dogs and in dogs with localized cutaneous lesions. J Vet Diagn Invest, 17, pp. 316-322.
10. Cafarchia, C., Gallo, S., Capelli, G. and Otranto, D. (2005) Occurrence and population size of Malassezia spp. in the external ear canal of dogs and cats both healthy and with otitis. Mycopathologia, 160, pp. 143-149.
11. Cafarchia, C. and Otranto, D. (2004) Association between phospholipase production by Malassezia pachydermatis and skin lesions. J Clin Microbiol, 42, pp. 4868-4869.
12. Pranab, KM and Mahmound, AG (2002) Fungal Pathogenesis: Principle and Clinical Applications, pp. 51-80. Marcel Dekker Inc.
13. Barret-Bee, K., Hayes, KY, Wilson, RG and Ryley, JF. (1985) A comparison of phospholipase activity, cellular adherence and pathogenicity of yeasts. J Gen Microbiol, 131, pp. 1217-1222.
14. Hanel, H., Menzel, I. and Holzman, H. (1988) High phospholipase A activity of Candida albicans isolated from intestine psoriatic patients. Mycoses, 31, pp. 451-453.
15. Price, MF, Wilkinson, ID and Gentry, LO. (1982) Plate method for detection of phospholipase activity of Candida albicans. Sabouraudia, 20, pp. 7-14.
16. Ibrahim, AS, Mirbod, F. and Filler, SG (1965) Evidence implicating phospholipase as a virulence factor of Candida albicans. Infect Immun, 63, pp. 1993-1998.
17. Mayser, P., Laabs, S., Heuer, KV and Grunder, K. (1996) Detection of extracellular phospholiphase activity in Candida albicans and Rhodotorula rubra. Mycopathologia, 135, pp. 149-155.
18. Chen, SC, Muller, M., Zhou, JZ, Wright, LC and Sorrell, TC. (1997) Phospholipase activity in Cryptococcus neoformans: A new virulence factor?. Infect Dis, 175, pp. 414-420.
19. Slominski, A. (2003) Beta-endorphin/mu-opiate receptor system in the skin. J Invest Dermatol, 120, pp. 1073-1080.
20. Slominski, A. (2005) Neuroendocrine system of the skin. Dermatology, 211, pp. 199-208.
21. Way, WL, Fields, HL and Leong, WE. (2000) Analgesici oppioidi e loro antagonisti. Farmacologia Generale e Clinica, pp. 527-546. Piccin Nuova Libreria, Padova
22. Corbett, A., McKnight, S. and Anderson, G. Opioid receptors. Tocris Cookson Pharmacological Review.
23. Pan, YX. (2005) Diversity and complexity of the mu opioid receptor gene: alternative pre-mRNA splicing and promoters. DNA Cell Biol, 24, pp. 736-750.
24. Pasternak, GW. (2004) Multiple opiate receptors: Deja vu all over again. Neuropharmacology, 47, pp. 312-323.
25. Bigliardi, PL, Bigliardi-Qi, M., Buechner, S. and Rufli, T. (1998) Expression of μ-opiate receptor in human epidermis and keratinocytes. J Invest Dermatol, 111, pp. 297-301.
26. Bigliardi-Qi, M., Bigliardi, PL, Eberle, AN, Buchner, S. and Rufli, T. (2000) Beta-endorphin stimulates cytokeratin 16 expression and downregulates mu-opiate receptor expression in human epidermis. J Invest Dermatol, 114, pp. 527-532.
27. Bigliardi-Qi, M., Sumanovski, LT, Buchner, S., Rufli, T. and Bigliardi, PL. (2004) Mu-opiate receptor and Beta-endorphin expression in nerve endings and keratinocytes in human skin. Dermatology, 209, pp. 183-189.
28. Bigliardi-Qi, M., Lipp, B., Sumanovski, L. T., Buechner, SA and Bigliardi, PL. (2005) Changes of epidermal mu-opiate receptor expression and nerve endings in chronic atopic dermatitis. Dermatology, 210, pp. 91-99.
29. Georgala, S., Schulpis, KH, Papaconstantinou, ED and Stratigos, J. (1994) Raised beta-endorphin serum levels in children with atopic dermatitis and pruritus. J Dermatol Sci, 8, pp. 125-128.
30. Glinski, W., Brodecka, H., Glinska-Ferenz, M. and Kowalski, D. (1994) Increased concentration of beta-endorphin in sera of patients with psoriasis and other inflammatory dermatoses. Br J Dermatol, 131, pp. 260-264.
31. Glinski, W., Brodecka, H., Glinska-Ferenz, M. and Kowalski, D. (1994) Neuropeptides in psoriasis: Possible role of beta-endorphin in the pathomechanism of the disease. Int J Dermatol, 33, pp. 356-360.
32. Dell'Aquila, ME, Casavola, V. and Reshkin, SJ (2002) Effects of beta-endorphin and Naloxone on in vitro maturation of bovine oocytes. Mol Reprod Dev, 63, pp. 210-222.
33. Sole, F Di, Guerra, L. and Bagorda, A. (2001) Naloxone inhibits A6 cell Na(+)/H(+) exchange by activating protein kinase C via the mobilization of intracellular calcium. Exp Nephrol, 9, pp. 341-348.
34. Witkin, SS and Kalo-Klein, A. (1991) Enhancement of germ tube formation in Candida albicans by beta-endorphin. Am J Obstet Gynecol, 164, pp. 917-920.